Ablation Devices: Technologies and Global Markets

Ablation Devices: Technologies and Global Markets

  • January 2017
  • 222 pages
  • BCC Research
Report ID: 2009158

Use this report to:
- Gain insight into key market dynamics and the factors impacting the global ablation market and its subsegments.
- Analyze global ablation market and its market segments, which include technologies, product categories, therapeutic markets and geographic segmentation.
- Identify major stakeholders, product portfolio and recent developments and draw a competitive landscape for the market leaders.
- Assess the number of patents awarded over the years across geographies such as the U.S., Europe, Japan, China and Rest of the World.



Highlights
- The global market for ablation devices reached $2.8 billion in 2015. The market should reach $3.1 billion in 2016 and $5.4 billion by 2021, growing at a compound annual growth rate (CAGR) of 11.6% from 2016 to 2021.
- The North American ablation devices market reached $1.6 billion in 2015. The market should reach $1.8 billion in 2016 and $3.1 billion by 2021, growing at a CAGR of 11.3% from 2016 to 2021.
- The Asia-Pacific market for ablation devices reached $235 million in 2015. The market should reach $264 million in 2016 and $492 million by 2021, growing at a CAGR of 13.3% from 2016 to 2021.


STUDY GOALS AND OBJECTIVE
- Define and identify key market segments and market structure in ablation technologies.
- Measure and estimate the global ablation market and its market segments, which include technologies, product categories, therapeutic markets and geographic segmentation.
- Identify key market dynamics and the factors impacting the global ablation market and its subsegments.
- Identify the trends, gaps and opportunities in each of the micromarkets.
- Focus exclusively on geographic segmentation. Analyze trends and opportunities in major regions: North America, Europe, Asia and the Rest of the World (ROW).
- Identify major stakeholders, product portfolio and recent developments and draw a competitive landscape for the market leaders.



STUDY BACKGROUND
Ablation is a minimally invasive surgical technique that involves destruction or removal of dysfunctional tissues to treat life-threatening diseases such as cancers, atrial fibrillation, etc. It is also equally adopted for simple treatments in cosmetology, orthopedics, uterine fibroids, etc. There is an increase in prevalence and incidents rates of lifestyle-oriented diseases and an increasing need to innovate minimally and noninvasive technologies to treat them. About 15% to 20% of ischemic strokes occur due to atrial fibrillation and about 12 million people in the U.S. are expected to suffer from this condition by 2050. Deaths due to cancers are reaching alarming rates across the globe. With numerous technologies available to control and treat cardiovascular disorders and cancer, these diseases still remain primary causes of death. Where conventional radiation therapies have been effective and been adopted due to high awareness levels, emerging technologies such as hydromechanical ablation, microwave and hydrothermal are increasing hopes among patients and healthcare service providers.

An increasingly aging population on one side and increasing healthcare expenditure on the other is becoming a major burden to governments across various countries. The regulatory and financial environment is getting significantly complex even in developed economies with governments focusing on cost-containment measures. The ablation procedure in this scenario is expected to be significantly preferred due to cost effectiveness (in comparison to conventional surgical techniques), shorter hospital stays, short recovery time, and lesser risk of blood loss and infections.

A high level of economic instability, growing pockets of investment in developing economies and commercialization of next-generation technologies are compelling market participants to collaborate and leverage. The current scenario requires the market players to plan exclusive strategies after an in-depth understanding of geographic, regulatory, technology and other key market factors.


SCOPE OF THE REPORT
This research report presents an in-depth analysis of the global ablation market by technologies, product categories, therapeutic segments, key procedures and geographic markets. The report includes key technologies involved in thermal ablation techniques and nonthermal ablation techniques. The report discusses the role of supply chain members from manufacturers to surgeons. The report has an in-depth analysis of key companies operating in the global ablation market. In-depth patent analysis in the report will focus on providing extensive technological trends across years and geographies such as the U.S., Europe and Japan.

The ablation devices market is mainly segmented into two classes: thermal and nonthermal technologies. Thermal technologies are further segmented into electrical, radiation, radio frequency, light, ultrasound, microwave and hydrothermal. The nonthermal technology market is segmented into cryotherapy and hydromechanical. The ablation devices technology market is further segmented on the basis of products offered for in-depth analysis of technology markets during the analysis period. The market study is detailed for technology based on procedures as well as its further implication on the therapeutic area. These two segmentations are also discussed in detail for the given period. The market is segmented by geography into the North America, Europe, Asia-Pacific and ROW. Companies profiled in this report include Conmed, Varian Medical Systems Inc., Medtronic Inc., Boston Scientific Corp., Olympus Corp., Smith & Nephew, C.R. Bard Inc., and others.



INTENDED AUDIENCE
The intended audience includes:
- Ablation technologies and device manufacturers and potential entrants.
- Dealers, distributors and service providers of ablation devices.
- Robotics, life science and surgical companies.
- Healthcare-oriented software and analytics companies.
- Research institutes, associations and academicians.

SOURCE OF INFORMATION AND METHODOLOGY

The global ablation market was assessed and calculated through a bottom-up approach that involved identifying the market revenues of the micromarkets that make up the macromarkets. The following process was followed to ensure quality and consistency of estimates.
- In-depth primary and secondary research was conducted.
- Primary research included gathering intelligence from key market players. The participants of the interview include chief executive officers, key opinion leaders, product heads and directors.
- Secondary research not only included collation of data from freely available sources but also paid subscriptions from specialized industry magazines and websites.
- To best assure triangulation of market estimates, the derived values where again validated through primary research.
- Key factors considered during market estimations were price, volumes, incidence and prevalence rates, number of procedures, etc.
- The geographic segmentation was assessed through various parameters such as the number of players in a particular region, incidence and prevalence rates, the extent of research activity occurring in that geography and future potential.



ANALYST'S CREDENTIALS

Yojana Jeevane has more than four years of experience in market intelligence and business research. She has experience in the healthcare domain with respect to medical devices, the life sciences market and the chemical domain. She has frequently delivered research services that contain strategic recommendations and top business strategies to assist the market players to make beneficial strategies. Ms. Jeevane holds an MBA in marketing.
CHAPTER 1
INTRODUCTION 2
STUDY GOALS AND OBJECTIVE 2
STUDY BACKGROUND 2
SCOPE OF THE REPORT 3
INTENDED AUDIENCE 3
SOURCE OF INFORMATION AND METHODOLOGY 3
ANALYST'S CREDENTIALS 4
RELATED BCC RESEARCH REPORTS 4
BCC RESEARCH WEBSITE 4
DISCLAIMER 5
CHAPTER 2 EXECUTIVE SUMMARY 7
SUMMARY TABLE GLOBAL MARKET FOR ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 8
SUMMARY FIGURE GLOBAL MARKET FOR ABLATION DEVICES BY REGION, 2015-2021 ($ MILLIONS) 8
CHAPTER 3 ABLATION MARKET OVERVIEW 11
ABLATION DEVICES: TECHNOLOGY TRENDS AND INNOVATIONS 11
TYPES OF CONVENTIONAL SURGICAL PROCEDURES AND DRAWBACKS 13
HEART SURGERY 13
PLASTIC SURGERY 14
BRAIN SURGERY 14
CANCER SURGERY 15
ORTHOPEDIC SURGERY 15
GOVERNMENT REGULATIONS, MEDICAL ASSOCIATIONS, FDA AND INTERNATIONAL REGULATORY AGENCIES 16
TABLE 1 DEVICES YET TO BE APPROVED FOR ATRIAL FIBRILLATION TREATMENT 17
INDUSTRY STRUCTURE AND SUPPLY CHAIN PROCESS 18
ROLE OF MANUFACTURERS 18
ROLE OF DISTRIBUTORS 19
ROLE OF RESEARCH INSTITUTE AND CONSULTANTS 19
ROLE OF GOVERNMENT 20
ROLE OF HOSPITALS AND SURGEONS 20
DEMOGRAPHICS, INCIDENCE AND PREVALENCE RATES AND OTHER PARAMETERS INFLUENCING MARKET GROWTH 21
INCIDENCE AND PREVALENCE OF CANCERS 21
TABLE 2 ESTIMATED CANCER DEMOGRAPHICS IN THE U.S., 2016 21
FIGURE 1 DEATHS DUE TO PROSTATE CANCER IN THE U.K., 2014 (%) 22
INCIDENCE AND PREVALENCE RELATING TO CVDS 23
TABLE 3 CARDIOVASCULAR DEMOGRAPHICS IN THE U.S., 2012 23
TABLE 4 EUROPEAN UNION STATISTICS OF CIRCULATORY DISEASES, 2012 24
FIGURE 2 DEATHS DUE TO CARDIOVASCULAR DISEASES IN EUROPE, 2014 (%) 24
FIGURE 3 PREVALENCE OF CIRCULATORY DISEASES IN ADULTS IN THE U.S., AGE GROUP 18 YEARS AND OVER, 2014 (%) 25
INCIDENCE AND PREVALENCE RELATING TO OPHTHALMOLOGY 26
TABLE 5 VISUAL IMPAIRMENT STATISTICS IN THE U.S., 2015 AND 2050 27
FIGURE 4 CAUSES OF VISUAL IMPAIRMENT, 2014 (%) 27
FIGURE 5 NO. OF PEOPLE WITH VISUAL IMPAIRMENT PER MILLION, 2010 (THOUSANDS) 27
FDA GUIDELINES FOR SELECTED PRODUCTS 29
TABLE 6 FDA GUIDELINES FOR SELECTED ABLATION DEVICES 29
REIMBURSEMENT SCENARIO 33
CODING CHANGES FOR CARDIOLOGY 33
ABLATION CODES 33
TABLE 7 FDA GUIDELINES FOR SELECTED ABLATION DEVICES 34
TABLE 8 PHYSICIAN FEE SCHEDULE CODES 38
COMPARISON OF 2012 AND 2013 CODES 38
Case Study I 39
Scenario: Evaluation for a possibility of thrombus before the procedure. 39
TABLE 9 ATRIAL FIBRILLATION ABLATION FOR PULMONARY VEIN ISOLATION 39
Case Study II 40
Scenario: Comprehensive diagnostics of electrophysiology evaluation with stimulation of arrhythmia. 40
TABLE 10 DIAGNOSTICS OF ELECTROPHYSIOLOGY STUDY 40
MARKET DYNAMICS 41
TECHNOLOGICAL DEVELOPMENTS 41
HIGHER RISK OF CHRONIC ILLNESSES 41
FIGURE 6 WORLD MORTALITY TRENDS DUE TO CARDIOVASCULAR DISEASES, 2008-2030 (%) 42
FIGURE 7 ESTIMATED NUMBER OF U.S. CANCER SURVIVORS BY SEX AND AGE, 2014 (MILLIONS) 42
TABLE 11 CANCER DEMOGRAPHICS IN EUROPE, 2012 43
ABLATION THERAPY REQUIRES LESS TIME 44
LESS DAMAGE AND BLOOD LOSS 44
RESTRAINTS FOR THE GLOBAL ABLATION DEVICES MARKET 45
PRESSURE FROM REGULATORY AGENCIES 45
INSURANCE SETTLEMENT ISSUES 45
OPPORTUNITIES AND CHALLENGES FOR THE ABLATION DEVICES MARKET 46
GROWING MARKETS IN EMERGING ECONOMIES 46
NEED TO ENHANCE AWARENESS LEVELS 46
CHAPTER 4 ABLATION MARKET ANALYSIS BY TECHNOLOGY 49
TABLE 12 GLOBAL MARKET FOR ABLATION DEVICES AND SERVICES, THROUGH 2021 ($ MILLIONS) 49
TABLE 13 GLOBAL MARKET FOR ABLATION DEVICES BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS) 49
THERMAL TECHNOLOGY MARKET 50
TABLE 14 GLOBAL MARKET FOR THERMAL ABLATION DEVICES BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS) 50
ELECTRICAL ABLATION THERAPY 51
TABLE 15 GLOBAL MARKET FOR ELECTRICAL ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 51
RADIATION TECHNOLOGY 52
TABLE 16 GLOBAL MARKET FOR RADIATION ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS) 53
Types of Radiation Ablation Techniques 53
Intensity-Modulated Radiation Therapy (IMRT) 53
Image-Guided Radiation Therapy (IGRT) 53
Helical Tomography 54
Particle Therapy 54
Stereotactic Radiotherapy 54
Brachytherapy 55
RADIO FREQUENCY (RFID) TECHNOLOGY 55
TABLE 17 GLOBAL MARKET FOR RADIO FREQUENCY ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS) 56
Uses of RFA 56
Key Applications of RFA 56
Specific Application of RFID in Therapeutic Segments 57
Treatment of Liver Cancer 57
Treatment of Kidney Cancer 57
Treatment of Lung Cancer 57
Arrhythmias 57
Arthritis Pain 57
Treatment of Varicose Veins 58
LIGHT 58
TABLE 18 GLOBAL MARKET FOR LIGHT/LASER ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS) 59
ULTRASOUND 59
TABLE 19 GLOBAL MARKET FOR ULTRASOUND ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS) 60
TABLE 20 HIFU STUDIES IN KIDNEY TISSUES BY COUNTRY 61
HIFU in Prostate Cancer 61
HIFU in Primary and Secondary Liver Cancer 61
HIFU in Pancreatic Cancer 62
HIFU in Bladder Cancer 62
MICROWAVE 62
TABLE 21 GLOBAL MARKET FOR MICROWAVE ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS) 63
HYDROTHERMAL 63
TABLE 22 GLOBAL MARKET FOR HYDROTHERMAL ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS) 64
NONTHERMAL ABLATION TECHNOLOGY 64
TABLE 23 GLOBAL MARKET FOR NONTHERMAL ABLATION TECHNOLOGY BY TYPE, THROUGH 2021 ($ MILLIONS) 65
CRYOABLATION 65
TABLE 24 GLOBAL MARKET FOR CRYOABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS) 66
HYDROMECHANICAL 66
TABLE 25 GLOBAL MARKET FOR HYDROMECHANICAL TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS) 67
CHAPTER 5 ABLATION MARKET ANALYSIS BY PRODUCTS 69
ELECTRICAL 69
TABLE 26 GLOBAL MARKET FOR ELECTRICAL ABLATION THERAPY BY PRODUCT, THROUGH 2021 ($ MILLIONS) 69
TABLE 27 GLOBAL MARKET FOR ELECTRICAL ABLATORS BY REGION, THROUGH 2021 ($ MILLIONS) 69
ELECTRICAL ABLATORS 70
TABLE 28 GLOBAL MARKET FOR ELECTRICAL ABLATOR BY PRODUCT, THROUGH 2021 ($ MILLIONS) 70
Argon Plasma/Beam Coagulator 70
TABLE 29 GLOBAL MARKET FOR ARGON PLASMA/BEAM COAGULATOR BY REGION, THROUGH 2021 ($ MILLIONS) 71
Irreversible Electroporation 71
TABLE 30 GLOBAL MARKET FOR IRREVERSIBLE ELECTROPORATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 71
ELECTRONIC BRACHYTHERAPY 72
TABLE 31 GLOBAL MARKET FOR ELECTRONIC BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 72
RADIATION 72
TABLE 32 GLOBAL MARKET FOR RADIATION THERAPY BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS) 73
BRACHYTHERAPY 73
TABLE 33 GLOBAL MARKET FOR BRACHYTHERAPY ABLATOR BY PRODUCTS, THROUGH 2021 ($ MILLIONS) 73
TABLE 34 GLOBAL MARKET FOR BRACHYTHERAPY ABLATOR BY REGION, THROUGH 2021 ($ MILLIONS) 74
High-Dose-Rate (HDR) Brachytherapy 74
TABLE 35 GLOBAL MARKET FOR HIGH-DOSE-RATE BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 74
Pulsed-Dose-Rate Brachytherapy 75
TABLE 36 GLOBAL MARKET FOR PULSE-DOSE-RATE BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 75
Permanent Seed Brachytherapy or Low-Dose-Rate (LDR) Brachytherapy 75
TABLE 37 GLOBAL MARKET FOR PERMANENT SEED BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 76
STEREOTACTIC RADIOSURGERY AND STEREOTACTIC RADIOTHERAPY 76
TABLE 38 GLOBAL MARKET FOR STEREOTACTIC RADIOSURGERY (SRS) AND STEREOTACTIC RADIOTHERAPY (SRT) BY REGION, THROUGH 2021 ($ MILLIONS) 77
IMAGE-GUIDED RADIATION THERAPY (IGRT) 77
TABLE 39 GLOBAL MARKET FOR IMAGE-GUIDED RADIATION THERAPY (IGRT) BY REGION, THROUGH 2021 ($ MILLIONS) 78
INTENSITY-MODULATED RADIATION THERAPY (IMRT) 78
TABLE 40 GLOBAL MARKET FOR INTENSITY-MODULATED RADIATION THERAPY (IMRT) BY REGION, THROUGH 2021 ($ MILLIONS) 78
STEREOTACTIC BODY RADIATION THERAPY (SBRT) 79
TABLE 41 GLOBAL MARKET FOR STEREOTACTIC BODY RADIATION THERAPY (SBRT) BY REGION, THROUGH 2021 ($ MILLIONS) 79
PROTON BEAM THERAPY 79
TABLE 42 GLOBAL MARKET FOR PROTON BEAM THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 80
RADIO FREQUENCY 80
TABLE 43 GLOBAL MARKET FOR RADIO FREQUENCY ABLATOR BY PRODUCT, THROUGH 2021 ($ MILLIONS) 80
TEMPERATURE-CONTROLLED RADIO FREQUENCY ABLATION DEVICES 81
TABLE 44 GLOBAL MARKET FOR TEMPERATURE-CONTROLLED RADIO FREQUENCY ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 81
FLUID-COOLED RF ABLATION 81
TABLE 45 GLOBAL MARKET FOR FLUID-COOLED RF ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 82
THE ROBOTIC CATHETER MANIPULATION SYSTEM 82
TABLE 46 GLOBAL MARKET FOR CATHETER MANIPULATION SYSTEM DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 82
LIGHT/LASER 83
TABLE 47 GLOBAL MARKET FOR LIGHT/LASER ABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS) 83
COLD LASER 83
TABLE 48 GLOBAL MARKET FOR COLD LASER DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 84
EXCIMER LASER 84
TABLE 49 GLOBAL MARKET FOR EXCIMER LASER DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 84
ULTRASOUND 85
TABLE 50 GLOBAL MARKET FOR ULTRASOUND ABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS) 85
HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) 85
TABLE 51 GLOBAL MARKET FOR HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) ABLATORS BY REGION, THROUGH 2021 ($ MILLIONS) 86
MAGNETIC RESONANCE-GUIDED ULTRASOUND (MRGFUS) 86
TABLE 52 GLOBAL MARKET FOR MAGNETIC RESONANCE-GUIDED ULTRASOUND (MRGFUS) ABLATORS BY REGION, THROUGH 2021 ($ MILLIONS) 87
ULTRASONIC SURGICAL SYSTEMS 87
TABLE 53 GLOBAL MARKET FOR ULTRASONIC SURGICAL SYSTEMS BY REGION, THROUGH 2021 ($ MILLIONS) 88
EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY 88
TABLE 54 GLOBAL MARKET FOR EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY PRODUCT BY REGION, THROUGH 2021 ($ MILLIONS) 88
MICROWAVE ABLATION 89
HYDROTHERMAL ABLATION/ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES 89
CRYOABLATION 90
TABLE 55 GLOBAL MARKET FOR CRYOABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS) 90
TISSUE CONTACT PROBE 90
TABLE 56 GLOBAL MARKET FOR TISSUE CONTACT PROBE BY REGION, THROUGH 2021 ($ MILLIONS) 91
TISSUE SPRAY PROBE 91
TABLE 57 GLOBAL MARKET FOR TISSUE SPRAY PROBE BY REGION, THROUGH 2021 ($ MILLIONS) 91
EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES 92
TABLE 58 GLOBAL MARKET FOR EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 93
ADVANCEMENT IN ROBOTIC ABLATION TECHNIQUE 93
VARIOUS PROCEDURES THAT ARE ROBOTIC IN NATURE 94
STEERABLE CATHETERS 94
HEARTLANDER 94
ROBOTIC RADIOTHERAPY 94
ROBOTIC ABLATION FOR ARRHYTHMIA 94
LEADING ROBOTIC SYSTEMS USED IN CATHETER ABLATION 95
Niobe (Stereotaxis) 95
Sensei (Hansen Medical) 95
Amigo (Catheter Robotics) 95
Artis Zeego (Siemens) 95
TABLE 59 GLOBAL MARKET FOR ROBOTIC ABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS) 95
TABLE 60 GLOBAL MARKET FOR ROBOTIC ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 96
TABLE 61 GLOBAL MARKET FOR AUTOMATED/ROBOTIC ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 96
TABLE 62 GLOBAL MARKET FOR CONVENTIONAL ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 96
CHAPTER 6 ABLATION MARKET ANALYSIS BY PROCEDURES 99
TABLE 63 GLOBAL MARKET FOR ABLATION DEVICES BY PROCEDURE, THROUGH 2021 ($ MILLIONS) 99
AESTHETICS-SKIN REJUVENATION AND TIGHTENING 99
TABLE 64 GLOBAL MARKET FOR AESTHETICS-SKIN REJUVENATION AND TIGHTENING BY REGION, THROUGH 2021 ($ MILLIONS) 99
LASER SKIN REJUVENATION 100
ILLUSTRATION: SOURCE-VICTORIAN COSMETIC INSTITUTE'S CASE STUDIES 100
RADIO FREQUENCY (RF) FOR FACIAL SKIN REJUVENATION 101
AESTHETICS-BODY SCULPTING, FAT REDUCTION AND REDUCTION IN THE APPEARANCE OF CELLULITE 102
TABLE 65 GLOBAL MARKET FOR AESTHETICS-BODY SCULPTING, FAT REDUCTION AND REDUCTION IN THE APPEARANCE OF CELLULITE BY REGION, THROUGH 2021 ($ MILLIONS) 102
HIFU FOR FAT REDUCTION 102
ILLUSTRATION: SOURCE-ELSEVIER HEALTH JOURNAL 103
VACUUM MASSAGE FOR CELLULITE REDUCTION 103
BENIGN PROSTATIC HYPERPLASIA 103
TABLE 66 GLOBAL MARKET FOR BENIGN PROSTATIC HYPERPLASIA BY REGION, THROUGH 2021 ($ MILLIONS) 104
GREENLIGHT LASER PROCEDURE FOR BENIGN PROSTATE 104
ILLUSTRATIONS: SOURCE-EUROPEAN UROLOGY CENTER 104
THERMOTHERAPY FOR BENIGN PROSTATE 105
TRANSURETHRAL NEEDLE ABLATION 105
TABLE 67 GLOBAL MARKET FOR TRANSURETHRAL NEEDLE ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 105
ILLUSTRATIONS: SOURCE-DIVISION OF UROLOGY, JOHANNESBURG HOSPITAL, SOUTH AFRICA 106
LASER AND OTHER ENERGY-BASED THERAPIES/HOLMIUM LASER ABLATION/ENUCLEATION OF THE PROSTATE 106
HOLMIUM LASER ENUCLEATION OF PROSTATE CANCER 106
TABLE 68 GLOBAL MARKET FOR LASER AND OTHER ENERGY-BASED ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 106
ILLUSTRATION 107
ATRIAL FIBRILLATION ABLATION 107
TABLE 69 GLOBAL MARKET FOR ATRIAL FIBRILLATION ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 108
PAROXYSMAL ATRIAL FIBRILLATION 108
PERSISTENT ATRIAL FIBRILLATION 108
CANCER/TUMOR ABLATION 109
TABLE 70 GLOBAL MARKET FOR TUMOR/CANCER ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 109
MENORRHAGIA/ENDOMETRIAL ABLATION 110
TABLE 71 GLOBAL MARKET FOR MENORRHAGIA/ENDOMETRIAL ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 111
HEATED BALLOON PROCEDURE 111
SPINAL DECOMPRESSION AND DENERVATION 112
TABLE 72 GLOBAL MARKET FOR SPINAL DECOMPRESSION AND DENERVATION ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 112
DIAGNOSTIC MEDIAL BRANCH BLOCK (MBB) 112
RADIO FREQUENCY ABLATION (RFA) FOR BACK PAIN 112
STRESS URINARY INCONTINENCE 113
TABLE 73 GLOBAL MARKET FOR STRESS URINARY INCONTINENCE ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 113
TRANSURETHRAL RADIO FREQUENCY COLLAGEN DENATURATION 113
VARICOSE VEIN ABLATION 114
TABLE 74 GLOBAL MARKET FOR VARICOSE VEIN ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 114
RADIO FREQUENCY ABLATION (RFA) FOR VARICOSE VEINS 115
UTERINE FIBROIDS 115
TABLE 75 GLOBAL MARKET FOR UTERINE FIBROIDS ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 116
HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) FOR TERINE FIBROIDS 116
OTHER PROCEDURES 116
TABLE 76 GLOBAL MARKET FOR OTHER ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 116
ELASA EYE SURGERY 117
CHAPTER 7 ABLATION MARKET ANALYSIS BY THERAPEUTICS 119
TABLE 77 GLOBAL MARKET FOR ABLATION THERAPEUTICS, THROUGH 2021 ($ MILLIONS) 119
CANCER/ONCOLOGY 119
TABLE 78 GLOBAL MARKET FOR CANCER ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 120
CARDIOVASCULAR 121
TABLE 79 GLOBAL MARKET FOR CARDIOVASCULAR ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 121
OPHTHALMOLOGY 122
TABLE 80 GLOBAL MARKET FOR OPHTHALMOLOGY ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 122
COSMETOLOGY 123
GYNECOLOGY 124
TABLE 81 GLOBAL MARKET FOR GYNECOLOGY ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 125
UROLOGY 125
TABLE 82 GLOBAL MARKET FOR UROLOGY ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 126
CRYOABLATION FOR PROSTATE CANCER 126
ORTHOPEDICS 127
TABLE 83 GLOBAL MARKET FOR ORTHOPEDICS THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 127
RADIO FREQUENCY ABLATION (RFA) FOR ORTHOPEDIC TREATMENT 128
PAIN MANAGEMENT 128
CRYOABLATION IN PAIN MANAGEMENT 129
OTHERS 129
TABLE 84 GLOBAL MARKET FOR OTHER THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 129
COBLATION FOR TONSILS 129
PORT-WINE STAINS 130
ABLATION OF PORT-WINE STAINS 130
CHAPTER 8 COMPETITIVE LANDSCAPE 132
FIGURE 8 KEY COMPETITIVE STRATEGIES, 2014-2016 (%) 133
CLEARANCES AND APPROVALS 133
FIGURE 9 CLEARANCE AND APPROVAL STRATEGY BY COMPANY, 2014-2016 (%) 134
TABLE 85 KEY CLEARANCES AND APPROVALS ANNOUNCED BETWEEN 2014 AND 2016 136
ACQUISITIONS 141
FIGURE 10 ACQUISITION STRATEGY BY COMPANIES, 2014-2016 (%) 142
TABLE 86 KEY ACQUISITIONS ANNOUNCED BETWEEN 2014 AND 2016 143
AGREEMENTS 147
FIGURE 11 AGREEMENT STRATEGY BY COMPANY, 2014-2016 (%) 148
TABLE 87 KEY AGREEMENTS ANNOUNCED BETWEEN 2014 AND 2016 148
PRODUCT LAUNCH 150
FIGURE 12 PRODUCT LAUNCH STRATEGY BY COMPANIES, 2014-2016 (%) 150
TABLE 88 KEY PRODUCT LAUNCH ANNOUNCED BETWEEN 2014 AND 2016 151
CHAPTER 9 GEOGRAPHIC ANALYSIS 154
NORTH AMERICA 154
TABLE 89 NORTH AMERICA ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS) 154
EUROPE 155
TABLE 90 EUROPEAN ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS) 155
ASIA-PACIFIC 156
TABLE 91 ASIA-PACIFIC ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS) 156
ROW 157
CHAPTER 10 PATENT ANALYSIS 160
FIGURE 13 SHARES OF PATENTS REGISTERED/APPROVED BY COUNTRY, 2013 THROUGH NOV. 2016 (%) 160
PATENT ANALYSIS BY MARKET PARTICIPANTS 161
FIGURE 14 PATENT SHARES BY MARKET PARTICIPANT, 2013 THROUGH NOV. 2016 (%) 162
PATENT ANALYSIS BY YEAR 162
FIGURE 15 PATENT ANALYSIS BY YEAR, 2013 THROUGH NOV. 2016 (%) 163
CHAPTER 11 COMPANY PROFILES 165
ABBOTT LABORATORIES 165
ABLATION PRODUCT PORTFOLIO 165
TABLE 93 ABBOTT LABORATORIES RECENT DEVELOPMENTS, 2014-2016 165
TABLE 94 ABBOTT LABORATORIES FINANCIALS, 2013-2015 ($ MILLIONS/%) 166
ACCURAY INC. 167
ACCURAY PRODUCT PORTFOLIO 167
TABLE 95 ACCURAY RECENT DEVELOPMENTS, 2014-2016 167
TABLE 96 ACCURAY FINANCIALS, 2013-2015 ($ MILLIONS/%) 168
ALCON LABORATORIES INC. 168
ABLATION PRODUCT PORTFOLIO 169
TABLE 97 ALCON RECENT DEVELOPMENTS, 2014-2016 169
TABLE 98 ALCON FINANCIALS, 2013-2015 ($ MILLIONS/%) 169
ANGIODYNAMICS INC. 170
ABLATION PRODUCT PORTFOLIO 170
TABLE 99 ANGIODYNAMICS RECENT DEVELOPMENTS, 2014-2016 171
TABLE 100 ANGIODYNAMICS FINANCIALS, 2013-2015 ($ MILLIONS/%) 171
ATRICURE INC. 171
ABLATION PRODUCT PORTFOLIO 172
TABLE 101 ATRICURE RECENT DEVELOPMENTS, 2014-2016 172
TABLE 102 ATRICURE FINANCIALS, 2013-2015 ($ MILLIONS/%) 173
BIOSENSE WEBSTER 173
ABLATION PRODUCT PORTFOLIO 174
TABLE 103 BIOSENSE WEBSTER RECENT DEVELOPMENTS, 2014-2016 174
TABLE 104 BIOSENSE WEBSTER FINANCIALS, 2013-2015 ($ MILLIONS/%) 175
BOSTON SCIENTIFIC CORP. 175
ABLATION PRODUCT PORTFOLIO 175
TABLE 105 BOSTON SCIENTIFIC CORP. RECENT DEVELOPMENTS, 2014-2016 176
TABLE 106 BOSTON SCIENTIFIC CORP. FINANCIALS, 2013-2015 ($ MILLIONS/%) 176
BTG PLC 177
ABLATION PRODUCT PORTFOLIO 177
TABLE 107 BTG PLC RECENT DEVELOPMENTS, 2014-2016 177
TABLE 108 BTG PLC FINANCIALS, 2013-2015 ($ MILLIONS/%) 178
CONMED CORP. 178
ABLATION PRODUCT PORTFOLIO 179
TABLE 109 CONMED RECENT DEVELOPMENTS, 2014-2016 179
TABLE 110 CONMED FINANCIALS, 2013-2015 ($ MILLIONS/%) 179
C.R. BARD INC. 180
ABLATION PRODUCT PORTFOLIO 180
TABLE 111 C.R. BARD RECENT DEVELOPMENTS, 2014-2016 181
TABLE 112 C.R. BARD FINANCIALS, 2013-2015 ($ MILLIONS/%) 181
EDAP TMS S.A. 181
ABLATION PRODUCT PORTFOLIO 182
TABLE 113 EDAP TMS S.A. RECENT DEVELOPMENTS, 2014-2016 182
TABLE 114 EDAP TMS S.A. FINANCIALS, 2013-2015 ($ MILLIONS/%) 182
ELEKTA AB 183
ABLATION PRODUCT PORTFOLIO 183
TABLE 115 ELEKTA AB RECENT DEVELOPMENTS, 2014-2016 183
TABLE 116 ELEKTA AB FINANCIALS, 2013-2015 ($ MILLIONS/%) 184
HAYLARD HEALTH INC. 184
ABLATION PRODUCT PORTFOLIO 185
TABLE 117 HAYLARD HEALTH INC. RECENT DEVELOPMENTS, 2014-2016 185
TABLE 118 HAYLARD HEALTH INC. FINANCIALS, 2013-2015 ($ MILLIONS/%) 186
HOLOGIC INC. 186
ABLATION PRODUCT PORTFOLIO 186
TABLE 119 HOLOGIC INC. RECENT DEVELOPMENTS, 2014-2016 187
TABLE 120 HOLOGIC INC. FINANCIALS, 2013-2015 ($ MILLIONS/%) 187
INTEGRA LIFESCIENCES HOLDINGS CORP. 187
ABLATION PRODUCT PORTFOLIO 188
TABLE 121 INTEGRA LIFESCIENCES HOLDINGS CORP. RECENT DEVELOPMENTS, 2014-2016 188
TABLE 122 INTEGRA LIFESCIENCES HOLDINGS CORP. FINANCIALS, 2013-2015 ($ MILLIONS/%) 189
JAPAN LIFELINE CO. LTD. 189
ABLATION PRODUCT PORTFOLIO 190
TABLE 123 JAPAN LIFELINE CO. LTD. RECENT DEVELOPMENTS, 2014-2016 190
TABLE 124 JAPAN LIFELINE CO. LTD. FINANCIALS, 2013-2015 ($ MILLIONS/%) 190
MEDTRONIC PLC 191
ABLATION PRODUCT PORTFOLIO 191
TABLE 125 MEDTRONIC PLC RECENT DEVELOPMENTS, 2014-2016 192
TABLE 126 MEDTRONIC PLC FINANCIALS, 2013-2015 ($ MILLIONS/%) 192
MERIT MEDICAL SYSTEMS INC. 193
ABLATION PRODUCT PORTFOLIO 193
TABLE 127 MERIT MEDICAL SYSTEMS INC. RECENT DEVELOPMENTS, 2014-2016 193
TABLE 128 MERIT MEDICAL SYSTEMS INC. FINANCIALS, 2013-2015 ($ MILLIONS/%) 194
MISONIX INC. 194
ABLATION PRODUCT PORTFOLIO 194
TABLE 129 MISONIX INC. RECENT DEVELOPMENTS, 2014-2016 195
TABLE 130 MISONIX FINANCIALS, 2013-2015 ($ MILLIONS/%) 195
OLYMPUS CORP. 195
ABLATION PRODUCT PORTFOLIO 196
TABLE 131 OLYMPUS RECENT DEVELOPMENTS, 2014-2016 196
TABLE 132 OLYMPUS FINANCIALS, 2013-2015 ($ MILLIONS/%) 197
SMITH & NEPHEW PLC 197
ABLATION PRODUCT PORTFOLIO 197
TABLE 133 SMITH & NEPHEW RECENT DEVELOPMENTS, 2014-2016 198
TABLE 134 SMITH & NEPHEW FINANCIALS, 2013-2015 ($ MILLIONS/%) 198
ST. JUDE MEDICAL INC. 198
ABLATION PRODUCT PORTFOLIO 199
TABLE 135 ST. JUDE MEDICAL RECENT DEVELOPMENTS, 2014-2016 199
TABLE 136 ST. JUDE MEDICAL FINANCIALS, 2013-2015 ($ MILLIONS/%) 200
STRYKER CORP. 200
ABLATION PRODUCT PORTFOLIO 200
TABLE 137 STRYKER CORP. RECENT DEVELOPMENTS, 2014-2016 201
TABLE 138 STRYKER CORP. FINANCIALS, 2013-2015 ($ MILLIONS/%) 202
TERUMO MEDICAL CORP. 202
ABLATION PRODUCT PORTFOLIO 202
TABLE 139 TERUMO MEDICAL CORP. RECENT DEVELOPMENTS, 2014-2016 202
TABLE 140 TERUMO MEDICAL CORP. FINANCIALS, 2013-2015 ($ MILLIONS/%) 203
VARIAN MEDICAL SYSTEMS INC. 203
ABLATION PRODUCT PORTFOLIO 204
TABLE 141 VARIAN MEDICAL SYSTEMS INC. RECENT DEVELOPMENTS, 2014-2016 204
TABLE 142 VARIAN MEDICAL SYSTEMS INC., 2013-2015 ($ MILLIONS/%) 205
CHAPTER 12 APPENDIX 207
TABLE 143 U.S. PATENTS, 2013 THROUGH OCT. 2016 207
TABLE 144 EUROPEAN PATENTS, 2013 THROUGH NOV. 2016 214
TABLE 145 JAPANESE PATENTS, 2013-2015 219
TABLE 146 CHINESE PATENTS, 2013-2015 220
TABLE 147 CANADIAN PATENTS, 2013-2015 223
TABLE 148 ROW PATENTS, 2013-2015 225


LIST OF TABLES
SUMMARY TABLE GLOBAL MARKET FOR ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 8
TABLE 1 DEVICES YET TO BE APPROVED FOR ATRIAL FIBRILLATION TREATMENT 17
TABLE 2 ESTIMATED CANCER DEMOGRAPHICS IN THE U.S., 2016 21
TABLE 3 CARDIOVASCULAR DEMOGRAPHICS IN THE U.S., 2012 23
TABLE 4 EUROPEAN UNION STATISTICS OF CIRCULATORY DISEASES, 2012 24
TABLE 5 VISUAL IMPAIRMENT STATISTICS IN THE U.S., 2015 AND 2050 27
TABLE 6 FDA GUIDELINES FOR SELECTED ABLATION DEVICES 29
TABLE 7 FDA GUIDELINES FOR SELECTED ABLATION DEVICES 34
TABLE 8 PHYSICIAN FEE SCHEDULE CODES 38
TABLE 9 ATRIAL FIBRILLATION ABLATION FOR PULMONARY VEIN ISOLATION 39
TABLE 10 DIAGNOSTICS OF ELECTROPHYSIOLOGY STUDY 40
TABLE 11 CANCER DEMOGRAPHICS IN EUROPE, 2012 43
TABLE 12 GLOBAL MARKET FOR ABLATION DEVICES AND SERVICES, THROUGH 2021 ($ MILLIONS) 49
TABLE 13 GLOBAL MARKET FOR ABLATION DEVICES BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS) 49
TABLE 14 GLOBAL MARKET FOR THERMAL ABLATION DEVICES BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS) 50
TABLE 15 GLOBAL MARKET FOR ELECTRICAL ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 51
TABLE 16 GLOBAL MARKET FOR RADIATION ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS) 53
TABLE 17 GLOBAL MARKET FOR RADIO FREQUENCY ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS) 56
TABLE 18 GLOBAL MARKET FOR LIGHT/LASER ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS) 59
TABLE 19 GLOBAL MARKET FOR ULTRASOUND ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS) 60
TABLE 20 HIFU STUDIES IN KIDNEY TISSUES BY COUNTRY 61
TABLE 21 GLOBAL MARKET FOR MICROWAVE ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS) 63
TABLE 22 GLOBAL MARKET FOR HYDROTHERMAL ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS) 64
TABLE 23 GLOBAL MARKET FOR NONTHERMAL ABLATION TECHNOLOGY BY TYPE, THROUGH 2021 ($ MILLIONS) 65
TABLE 24 GLOBAL MARKET FOR CRYOABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS) 66
TABLE 25 GLOBAL MARKET FOR HYDROMECHANICAL TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS) 67
TABLE 26 GLOBAL MARKET FOR ELECTRICAL ABLATION THERAPY BY PRODUCT, THROUGH 2021 ($ MILLIONS) 69
TABLE 27 GLOBAL MARKET FOR ELECTRICAL ABLATORS BY REGION, THROUGH 2021 ($ MILLIONS) 69
TABLE 28 GLOBAL MARKET FOR ELECTRICAL ABLATOR BY PRODUCT, THROUGH 2021 ($ MILLIONS) 70
TABLE 29 GLOBAL MARKET FOR ARGON PLASMA/BEAM COAGULATOR BY REGION, THROUGH 2021 ($ MILLIONS) 71
TABLE 30 GLOBAL MARKET FOR IRREVERSIBLE ELECTROPORATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 71
TABLE 31 GLOBAL MARKET FOR ELECTRONIC BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 72
TABLE 32 GLOBAL MARKET FOR RADIATION THERAPY BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS) 73
TABLE 33 GLOBAL MARKET FOR BRACHYTHERAPY ABLATOR BY PRODUCTS, THROUGH 2021 ($ MILLIONS) 73
TABLE 34 GLOBAL MARKET FOR BRACHYTHERAPY ABLATOR BY REGION, THROUGH 2021 ($ MILLIONS) 74
TABLE 35 GLOBAL MARKET FOR HIGH-DOSE-RATE BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 74
TABLE 36 GLOBAL MARKET FOR PULSE-DOSE-RATE BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 75
TABLE 37 GLOBAL MARKET FOR PERMANENT SEED BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 76
TABLE 38 GLOBAL MARKET FOR STEREOTACTIC RADIOSURGERY (SRS) AND STEREOTACTIC RADIOTHERAPY (SRT) BY REGION, THROUGH 2021 ($ MILLIONS) 77
TABLE 39 GLOBAL MARKET FOR IMAGE-GUIDED RADIATION THERAPY (IGRT) BY REGION, THROUGH 2021 ($ MILLIONS) 78
TABLE 40 GLOBAL MARKET FOR INTENSITY-MODULATED RADIATION THERAPY (IMRT) BY REGION, THROUGH 2021 ($ MILLIONS) 78
TABLE 41 GLOBAL MARKET FOR STEREOTACTIC BODY RADIATION THERAPY (SBRT) BY REGION, THROUGH 2021 ($ MILLIONS) 79
TABLE 42 GLOBAL MARKET FOR PROTON BEAM THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 80
TABLE 43 GLOBAL MARKET FOR RADIO FREQUENCY ABLATOR BY PRODUCT, THROUGH 2021 ($ MILLIONS) 80
TABLE 44 GLOBAL MARKET FOR TEMPERATURE-CONTROLLED RADIO FREQUENCY ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 81
TABLE 45 GLOBAL MARKET FOR FLUID-COOLED RF ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 82
TABLE 46 GLOBAL MARKET FOR CATHETER MANIPULATION SYSTEM DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 82
TABLE 47 GLOBAL MARKET FOR LIGHT/LASER ABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS) 83
TABLE 48 GLOBAL MARKET FOR COLD LASER DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 84
TABLE 49 GLOBAL MARKET FOR EXCIMER LASER DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 84
TABLE 50 GLOBAL MARKET FOR ULTRASOUND ABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS) 85
TABLE 51 GLOBAL MARKET FOR HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) ABLATORS BY REGION, THROUGH 2021 ($ MILLIONS) 86
TABLE 52 GLOBAL MARKET FOR MAGNETIC RESONANCE-GUIDED ULTRASOUND (MRGFUS) ABLATORS BY REGION, THROUGH 2021 ($ MILLIONS) 87
TABLE 53 GLOBAL MARKET FOR ULTRASONIC SURGICAL SYSTEMS BY REGION, THROUGH 2021 ($ MILLIONS) 88
TABLE 54 GLOBAL MARKET FOR EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY PRODUCT BY REGION, THROUGH 2021 ($ MILLIONS) 88
TABLE 55 GLOBAL MARKET FOR CRYOABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS) 90
TABLE 56 GLOBAL MARKET FOR TISSUE CONTACT PROBE BY REGION, THROUGH 2021 ($ MILLIONS) 91
TABLE 57 GLOBAL MARKET FOR TISSUE SPRAY PROBE BY REGION, THROUGH 2021 ($ MILLIONS) 91
TABLE 58 GLOBAL MARKET FOR EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 93
TABLE 59 GLOBAL MARKET FOR ROBOTIC ABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS) 95
TABLE 60 GLOBAL MARKET FOR ROBOTIC ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 96
TABLE 61 GLOBAL MARKET FOR AUTOMATED/ROBOTIC ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 96
TABLE 62 GLOBAL MARKET FOR CONVENTIONAL ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 96
TABLE 63 GLOBAL MARKET FOR ABLATION DEVICES BY PROCEDURE, THROUGH 2021 ($ MILLIONS) 99
TABLE 64 GLOBAL MARKET FOR AESTHETICS-SKIN REJUVENATION AND TIGHTENING BY REGION, THROUGH 2021 ($ MILLIONS) 99
TABLE 65 GLOBAL MARKET FOR AESTHETICS-BODY SCULPTING, FAT REDUCTION AND REDUCTION IN THE APPEARANCE OF CELLULITE BY REGION, THROUGH 2021 ($ MILLIONS) 102
TABLE 66 GLOBAL MARKET FOR BENIGN PROSTATIC HYPERPLASIA BY REGION, THROUGH 2021 ($ MILLIONS) 104
TABLE 67 GLOBAL MARKET FOR TRANSURETHRAL NEEDLE ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 105
TABLE 68 GLOBAL MARKET FOR LASER AND OTHER ENERGY-BASED ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 106
TABLE 69 GLOBAL MARKET FOR ATRIAL FIBRILLATION ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 108
TABLE 70 GLOBAL MARKET FOR TUMOR/CANCER ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 109
TABLE 71 GLOBAL MARKET FOR MENORRHAGIA/ENDOMETRIAL ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 111
TABLE 72 GLOBAL MARKET FOR SPINAL DECOMPRESSION AND DENERVATION ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 112
TABLE 73 GLOBAL MARKET FOR STRESS URINARY INCONTINENCE ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 113
TABLE 74 GLOBAL MARKET FOR VARICOSE VEIN ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 114
TABLE 75 GLOBAL MARKET FOR UTERINE FIBROIDS ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 116
TABLE 76 GLOBAL MARKET FOR OTHER ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS) 116
TABLE 77 GLOBAL MARKET FOR ABLATION THERAPEUTICS, THROUGH 2021 ($ MILLIONS) 119
TABLE 78 GLOBAL MARKET FOR CANCER ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 120
TABLE 79 GLOBAL MARKET FOR CARDIOVASCULAR ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 121
TABLE 80 GLOBAL MARKET FOR OPHTHALMOLOGY ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 122
TABLE 81 GLOBAL MARKET FOR GYNECOLOGY ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 125
TABLE 82 GLOBAL MARKET FOR UROLOGY ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 126
TABLE 83 GLOBAL MARKET FOR ORTHOPEDICS THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 127
TABLE 84 GLOBAL MARKET FOR OTHER THERAPY BY REGION, THROUGH 2021 ($ MILLIONS) 129
TABLE 85 KEY CLEARANCES AND APPROVALS ANNOUNCED BETWEEN 2014 AND 2016 136
TABLE 86 KEY ACQUISITIONS ANNOUNCED BETWEEN 2014 AND 2016 143
TABLE 87 KEY AGREEMENTS ANNOUNCED BETWEEN 2014 AND 2016 148
TABLE 88 KEY PRODUCT LAUNCH ANNOUNCED BETWEEN 2014 AND 2016 151
TABLE 89 NORTH AMERICA ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS) 154
TABLE 90 EUROPEAN ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS) 155
TABLE 91 ASIA-PACIFIC ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS) 156
TABLE 92 ROW ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLI
Country=World Industry=Pathology ParentIndustry=Healthcare Date=201701 Topic=MarketReport Publisher=BCCResearch Price=6000